×

img Acces sibility Controls

Technologies Banner

All Technologies

Process Development of Drugs Repurposed for COVID-19

Implementing Organization

National Institute for Interdisciplinary Science and Technology (NIIST)

About

Process developed for Nitazoxanide, EIDD 1931 & EIDD 2801. Non-infringing routes developed for the APIs. Nitazoxanide is currently under clinical trials in Mexico. EIDD 2801 is currently under clinical trials in USA & UK.
Quick Information
Thrust Areas
Life Sciences & Biotechnology
Focus Area
Development of Repurposed Drugs for COVID-19
Status
completed
Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
arrowtop
Latest Updates
Loading…